LimaCorporate to Launch Study of SMR Stemless Reverse Shoulder

LimaCorporate SMR Stemless Reverse Shoulder

FDA approved the Investigational Device Exemption to start a clinical trial of LimaCorporate's SMR Stemless Reverse Shoulder.

In 1Q21, Lima will commence a randomized, 7-site comparative clinical trial in the U.S. to compare SMR Stemless to the SMR Reverse Shoulder in total reverse shoulder arthroplasty. The trial will enroll 200 patients....

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us